Discontinuation and reinitiation of pharmacological treatment for ADHD among individuals with ADHD and substance use disorder - PubMed
5 hours ago
- #Pharmacological Treatment
- #ADHD
- #Substance Use Disorder
- ADHD and substance use disorder (SUD) often coexist, complicating disease course.
- Study explores how comorbid SUD affects ADHD medication discontinuation and reinitiation.
- Individuals with ADHD and SUD were nearly twice as likely to discontinue ADHD treatment within a year.
- They were also less likely to re-initiate ADHD treatment compared to controls.
- Factors like male sex, young age, and lower stimulant dose increased discontinuation risk.
- Only young age was significantly associated with treatment reinitiation in ADHD and SUD cases.
- Findings suggest less treatment continuity and access for those with ADHD and comorbid SUD.
- Providers need to address specific needs of ADHD and SUD patients, especially young males.